Answers are grounded in this paper and cite their sources.
Ischemic stroke (IS) disrupts intestinal homeostasis through autonomic, endocrine, hemodynamic, and immune pathways, allowing gut-derived signals to influence secondary brain injury and recovery. Gut microbiota-derived extracellular vesicles (GMEVs) are membrane-enclosed particles that protect and transport bacterial proteins, lipids, glycans, nucleic acids, and metabolites across biological barriers. This narrative review examines how GMEVs may connect post-stroke dysbiosis and intestinal barrier dysfunction with peripheral immune activation, blood-brain barrier injury, glial responses, and neurovascular repair. Pathobiont-derived vesicles may promote endothelial activation, complement and inflammasome signaling, oxidative stress, leukocyte recruitment, and regulated cell death. Conversely, vesicles from selected commensal or probiotic bacteria may support epithelial integrity, immune resolution, and restorative signaling. Engineered bacterial vesicles have also shown therapeutic potential as targeted carriers in preclinical ischemic stroke models, although these studies do not establish equivalent effects for endogenous gut-derived vesicles. Depending on microbial source, cargo, route, dose, host state, and timing, vesicle-associated signaling could contribute to worsening or improvement rather than necessarily producing both outcomes. Translation will require source-resolved tracing, rigorous vesicle characterization, physiologic dosing, clinically relevant models, and longitudinal human studies.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: